ResearchA proof-of-principle study of the short-term effects of MDMA (3,4-methylenedioxymethamphetamine) on tinnitus and neural connectivity
ResearchBlast Trauma-Induced Tinnitus vs. Noise Trauma-Induced Tinnitus: Similarities and Differences
ResearchMedicines discovery for auditory disorders (including potential treatments for tinnitus): Challenges for industry
NewsFrequency Therapeutics CEO: “We have opened all U.S. sites for our Phase 2a study of FX-322 and remain on track to report top-line data in the second half of next year.”
NewsRESEARCH: Experimental procedure enables suppression of auditory cortex alpha activity in patients with chronic tinnitus
ResearchReal-time monitoring and regulating auditory cortex alpha activity in patients with chronic tinnitus
ResearchThe effect of transcutaneous electrical nerve stimulation (TENS) on chronic subjective tinnitus
NewsFrequency Therapeutics Begins Recruiting for Phase 2 Study of FX-322 in Patients with Sensorineural Hearing Loss
Clinical TrialsEffects of Sound Stimulation, Somatosensory Stimulation, Vestibular Stimulation and the Combinations on Tinnitus Loudness and Tinnitus Related Distress in Patients
NewsNeuromod (Lenire) Clinical Trial Data “Locked” Until Fall 2020? Study Results “Delayed” Until 2021?
ResearchNoninvasive Bimodal Neuromodulation for the Treatment of Tinnitus: Protocol for a Second Large-Scale Double-Blind Randomized Clinical Trial to Optimize Stimulation Parameters
NewsNeuromod Successfully Closes €8 Million Capital Raise: proceeds will be used to accelerate ongoing commercialization of Lenire® tinnitus treatment device
Clinical TrialsA Phase-II Clinical Trial on the Effectiveness of Antioxidant Supplementation in Idiopathic Tinnitus Patients [Completed]
ResearchEfficacy and safety of bilateral caudate nucleus deep brain stimulation (DBS) for treatment-resistant tinnitus
NewsAuris Medical Receives FDA and EMA Guidance for Keyzilen® (AM-101) Late-Stage Clinical Development Program
ResearchA Prospective Study to Evaluate Effectiveness of a Tinnitus Relief Device (TRx) in a Clinical Setup
ResearchMemantine Attenuates Salicylate-induced Tinnitus Possibly by Reducing NR2B Expression in Auditory Cortex of Rat
ResearchInhibition of Brain Area and Functional Connectivity in Idiopathic Sudden Sensorineural Hearing Loss With Tinnitus
ResearchSound therapy (using amplification devices and/or sound generators) for tinnitus: insufficient evidence of improvement over placebo
NewsFrequency Therapeutics prepares to advance first-in-class drug candidate FX-322 into Phase 2a study…
NewsOtonomy Expands Recruiting Locations for Phase 1/2 Clinical Trial of OTO-313 in Patients with Subjective Tinnitus
NewsThe Truth About Tinnitus Habituation: Deficient Sensory Gating Could Explain Why Many Tinnitus Victims Do Not Habituate
NewsFrequency Therapeutics licenses FX-322 outside U.S. to Astellas Pharma for $80M. Both companies will work on global clinical trials for the treatment and coordinate launch efforts.
NewsNew Treatment-Related Research from Dr. Susan Shore: Mechanisms of Noise-Induced Tinnitus: Insights from Cellular Studies
NewsResearch Roundup: 20+ field reports from the Tinnitus Research Initiative (TRI) 2019 Conference in Taipei
NewsNew findings support the view that tinnitus could be a proprioceptive illusion related to the middle-ear muscles
ResearchMechanism of acupuncture efficacy on tinnitus: acupuncture associated with improvement of cochlear blood flow via infrared thermography test
UncategorizedRISE OF THE PLACEBOS: repetitive Transcranial Magnetic Stimulation (rTMS) is NOT an effective treatment for chronic tinnitus, new research suggests
ResearchTreatment of Tinnitus Using Theta Burst Based Repetitive Transcranial Magnetic Stimulation-A Single Blinded Randomized Control Trial
NewsDrug to reduce brain inflammation cured tinnitus in mice – paving the way towards a pill for humans
NewsSound Pharmaceuticals Completes Phase 2 Study of SPI-1005 for the Treatment of Tinnitus and Vertigo in Patients with Meniere’s Disease
UncategorizedClosing in on tinnitus treatments: New research aims to capture and eventually cure incessant ringing in the ears [Note: Paywall]
ResearchEffect of electrical stimulation at auricular points combined with sound masking on the expression of CREB, BDNF and TrkB in the auditory cortex of tinnitus rats
NewsUPDATE: Frequency Therapeutics to present newest FX-322 clinical trial results on September 17, 2019 [early]
NewsWhat’s really going on in the world of tinnitus research? Seven insights from the #TRI2019 Conference…
Clinical TrialsImplantation of an Auditory Brainstem Implant for the Treatment of Incapacitating Unilateral Tinnitus
NewsNew study results raise serious concerns about effectiveness of Tinnitus Retraining Therapy (TRT)
ResearchEffect of Tinnitus Retraining Therapy vs Standard of Care on Tinnitus-Related Quality of Life: A Randomized Clinical Trial
ResearchChanges in gene expression following sudden loss of auditory input in one ear may contribute to perceptual disorders such as tinnitus and hyperacusis
Clinical TrialsIndividualized Treatment of Patients With Chronic Tinnitus With Repetitive Transcranial Magnetic Stimulation
NewsFrequency Therapeutics to present major FX-322 update on September 18, 2019 at AAO-HNSF Annual Meeting in New Orleans
ResearchTinnitus-related hyper-excitation is suppressed by inhibitory dual-site repetitive transcranial magnetic stimulation (rTMS)
NewsPossible tinnitus remedy uncovered during ethnobotanical study of medicinal plants used in Central Macedonia, Greece
NewsMajor analysis of tinnitus patients’ hearing loss points to “stochastic resonance” (SR) as root cause of tinnitus
ResearchThe short-term effects of recorded ocean sound with and without alpha frequency binaural beats on tinnitus perception
NewsNeuromod Broadens Senior Leadership Team in Preparation for Global Commercialisation of Lenire™ Tinnitus Treatment
NewsFirst study investigating the relationship between chronic tinnitus and peripheral blood derived BDNF/ GDNF promoter methylations
ResearchRelationship between chronic tinnitus and peripheral blood derived BDNF/GDNF promoter methylations
NewsNEUROMOD VIDEO: “New Treatment for Tinnitus Evaluated in over 500 Patients” [Dr. Hubert Lim presentation]
Clinical TrialsAcoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus [Withdrawn (Lack of funding and personnel)]
NewsPhase 1/2 clinical trial of OTO-313 (single intratympanic injection) in patients with subjective tinnitus is now recruiting
UncategorizedDoes Conservative Temporomandibular Therapy Affect Tinnitus Complaints? A Systematic Review
NewsOtonomy Initiates Phase 1/2 Clinical Trial to evaluate the therapeutic potential of OTO-313 in patients with tinnitus
ResearchAn Overview of Emerging Therapeutics for Inner Ear and Central Hearing Disorders Affecting Hearing, Balance and Tinnitus Pathways